Antagonism of Human Formyl Peptide Receptor 1 with Natural Compounds and Their Synthetic Derivatives

Overview

Journal Int Immunopharmacol

Specialties Allergy & Immunology
Pharmacology

Date 2015 Sep 19

PMID 26382576

Citations 20

Authors

Igor A Schepetkin

Andrei I Khlebnikov

Liliya N Kirpotina

Mark T Quinn

Affiliations

Soon will be listed here.

Abstract

Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases. To date, a variety of natural and synthetic molecules have been identified as FPR1 ligands. Here, we review current knowledge on natural products and natural product-inspired small molecules reported to antagonize and/or inhibit the FPR1-mediated responses. Based on this literature, additional screening of selected commercially available natural compounds for their ability to inhibit fMLF-induced Ca(2+) mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review. The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.

Citing Articles

Focusing on Formyl Peptide Receptors after Traumatic Spinal Cord Injury: from Immune Response to Neurogenesis.

Pu Z, Luo D, Shuai B, Xu Y, Liu M, Zhao J Neurochem Res. 2025; 50(2):98.

PMID: 39920516 DOI: 10.1007/s11064-025-04347-5.

The small molecule peptide ANXA114-26 inhibits ovarian cancer cell proliferation and reverses cisplatin resistance by binding to the formyl peptide receptors receptor.

Li N, Yan P, Guo L, Wang H, Cui B, Teng L J Cell Commun Signal. 2024; 19(1):e12058.

PMID: 39712859 PMC: 11659116. DOI: 10.1002/ccs3.12058.

Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist.

De Fenza M, Locri F, Plastino F, Chino M, Maglio O, Leone L ACS Pharmacol Transl Sci. 2024; 7(11):3476-3487.

PMID: 39539264 PMC: 11555506. DOI: 10.1021/acsptsci.4c00366.

Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction.

Lee B, Lee S, Song J, Choi J Biomol Ther (Seoul). 2024; 32(4):403-423.

PMID: 38898687 PMC: 11214962. DOI: 10.4062/biomolther.2024.009.

Druggable targets for the immunopathy of Alzheimer's disease.

Weaver D RSC Med Chem. 2023; 14(9):1645-1661.

PMID: 37731705 PMC: 10507808. DOI: 10.1039/d3md00096f.

References

Salari H, Braquet P, Borgeat P . Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med. 1984; 13(1):53-60. DOI: 10.1016/0262-1746(84)90102-1. View

Wu Y, Sureshbabu M, Fang Y, Wu Y, Lan Y, Chang F . Potent inhibition of human neutrophil activations by bractelactone, a novel chalcone from Fissistigma bracteolatum. Toxicol Appl Pharmacol. 2012; 266(3):399-407. DOI: 10.1016/j.taap.2012.11.021. View

Selvatici R, Falzarano S, Mollica A, Spisani S . Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol. 2006; 534(1-3):1-11. DOI: 10.1016/j.ejphar.2006.01.034. View

Sultana N, Saeed Saify Z . Naturally occurring and synthetic agents as potential anti-inflammatory and immunomodulants. Antiinflamm Antiallergy Agents Med Chem. 2012; 11(1):3-19. DOI: 10.2174/187152312803476264. View

Wang J, Hsu M, Raung S, Chang L, Tsao L, Lin P . Inhibition by magnolol of formylmethionyl-leucyl-phenyl alanine-induced respiratory burst in rat neutrophils. J Pharm Pharmacol. 1999; 51(3):285-94. DOI: 10.1211/0022357991772466. View

Boulay F, Tardif M, Brouchon L, VIGNAIS P . Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun. 1990; 168(3):1103-9. DOI: 10.1016/0006-291x(90)91143-g. View

Ptasznik A, Bokoch G . G protein-coupled chemoattractant receptors regulate Lyn tyrosine kinase.Shc adapter protein signaling complexes. J Biol Chem. 1995; 270(34):19969-73. DOI: 10.1074/jbc.270.34.19969. View

Huang Y, Chen I, Tseng C, Day Y, Lin Y, Liao C . (2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils. Biochem Pharmacol. 2007; 75(3):688-97. DOI: 10.1016/j.bcp.2007.10.002. View

Beuers U, Thiel M, Bardenheuer H, Paumgartner G . Tauroursodeoxycholic acid inhibits the cytosolic Ca++ increase in human neutrophils stimulated by formyl-methionyl-leucyl-phenylalanine. Biochem Biophys Res Commun. 1990; 171(3):1115-21. DOI: 10.1016/0006-291x(90)90800-3. View

10.

Fylaktakidou K, Hadjipavlou-Litina D, Litinas K, Nicolaides D . Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities. Curr Pharm Des. 2004; 10(30):3813-33. DOI: 10.2174/1381612043382710. View

11.

Zhang M, Liu G, Tang S, Song S, Yamashita K, Manabe M . Effect of five triterpenoid compounds from the buds of Aralia elata on stimulus-induced superoxide generation, tyrosyl phosphorylation and translocation of cytosolic compounds to the cell membrane in human neutrophils. Planta Med. 2006; 72(13):1216-22. DOI: 10.1055/s-2006-951679. View

12.

Wang J, Chen C . Magnolol induces cytosolic-free Ca2+ elevation in rat neutrophils primarily via inositol trisphosphate signalling pathway. Eur J Pharmacol. 1998; 352(2-3):329-34. DOI: 10.1016/s0014-2999(98)00363-x. View

13.

Kostenis E, Conklin B, Wess J . Molecular basis of receptor/G protein coupling selectivity studied by coexpression of wild type and mutant m2 muscarinic receptors with mutant G alpha(q) subunits. Biochemistry. 1997; 36(6):1487-95. DOI: 10.1021/bi962554d. View

14.

Haas P, de Haas C, Kleibeuker W, Poppelier M, van Kessel K, Kruijtzer J . N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. J Immunol. 2004; 173(9):5704-11. DOI: 10.4049/jimmunol.173.9.5704. View

15.

OCallaghan K, Kuliopulos A, Covic L . Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development. J Biol Chem. 2012; 287(16):12787-96. PMC: 3339939. DOI: 10.1074/jbc.R112.355461. View

16.

Hwang T, Hung C, Hsu C, Huang Y, Tsai Y, Hsieh P . Design and synthesis of tryptophan containing dipeptide derivatives as formyl peptide receptor 1 antagonist. Org Biomol Chem. 2013; 11(22):3742-55. DOI: 10.1039/c3ob40215k. View

17.

Feisst C, Pergola C, Rakonjac M, Rossi A, Koeberle A, Dodt G . Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo. Cell Mol Life Sci. 2009; 66(16):2759-71. PMC: 11115900. DOI: 10.1007/s00018-009-0078-3. View

18.

Chen J, Ting C, Hwang T, Chen I . Benzophenone derivatives from the fruits of Garcinia multiflora and their anti-inflammatory activity. J Nat Prod. 2009; 72(2):253-8. DOI: 10.1021/np8006364. View

19.

Wright A, Higginbottom A, Philippe D, Upadhyay A, Bagby S, Read R . Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response. Mol Immunol. 2007; 44(10):2507-17. PMC: 2646901. DOI: 10.1016/j.molimm.2006.12.022. View

20.

Liaw C, Lin Y, Lin Y, Chen C, Hwang T, Shen Y . Four new briarane diterpenoids from Taiwanese gorgonian Junceella fragilis. Mar Drugs. 2013; 11(6):2042-53. PMC: 3721220. DOI: 10.3390/md11062042. View